Insulet (PODD) Net Cash Flow (QoQ) (2010 - 2026)
Insulet (PODD) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Insulet | 10.34 Bn | 9.80 Bn | 562.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 123.52% |
| Mar 31, 2026 | -456.67% |
| Dec 31, 2025 | 88.41% |
| Sep 30, 2025 | -112.74% |
| Jun 30, 2025 | -152.26% |
| Mar 31, 2025 | 455.20% |
| Dec 31, 2024 | -23.87% |
| Sep 30, 2024 | 9.05% |
| Jun 30, 2024 | 42.83% |
| Mar 31, 2024 | 213.29% |
| Dec 31, 2023 | -40.38% |
| Sep 30, 2023 | 9.96% |
| Jun 30, 2023 | 144.88% |
| Mar 31, 2023 | -2.87% |
| Dec 31, 2022 | -376.19% |
| Sep 30, 2022 | 950.00% |
| Jun 30, 2022 | 102.22% |
| Mar 31, 2022 | -27.60% |
| Dec 31, 2021 | -1,609.52% |
| Sep 30, 2021 | -88.10% |